RecruitingNot ApplicableNCT04296487

Introduction of ACI for Cartilage Repair

Introduction of Autologous Chondrocyte Implantation Procedure for the Treatment of Chondral Defect in the Knee

Sponsor

Centre Hospitalier Universitaire Vaudois

Enrollment

218 participants

Start Date

Sep 1, 2017

Study Type

INTERVENTIONAL

Conditions

Chondral Defect Articular Cartilage Defect Osteochondritis

Summary

This study was aimed to evaluate effectiveness and safety of autologous chondrocyte suspension for treatment of knee articular cartilage defects.

Eligibility

Min Age: 15 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying autologous chondrocytes for people with articular cartilage defect, chondral defect, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 15 Years to 50 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.